15-89665828-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_002666.5(PLIN1):c.1324G>A(p.Gly442Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000988 in 1,416,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_002666.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLIN1 | NM_002666.5 | c.1324G>A | p.Gly442Ser | missense_variant | 9/9 | ENST00000300055.10 | NP_002657.3 | |
PLIN1 | NM_001145311.2 | c.1324G>A | p.Gly442Ser | missense_variant | 9/9 | NP_001138783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLIN1 | ENST00000300055.10 | c.1324G>A | p.Gly442Ser | missense_variant | 9/9 | 1 | NM_002666.5 | ENSP00000300055.5 | ||
PLIN1 | ENST00000430628.2 | c.1324G>A | p.Gly442Ser | missense_variant | 9/9 | 5 | ENSP00000402167.2 | |||
PLIN1 | ENST00000560330.1 | c.124-887G>A | intron_variant | 5 | ENSP00000453426.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000308 AC: 2AN: 64868Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 37042
GnomAD4 exome AF: 0.00000948 AC: 12AN: 1265676Hom.: 0 Cov.: 30 AF XY: 0.00000970 AC XY: 6AN XY: 618710
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151168Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73738
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at